TB-MBLA listed in the 2021 Pipeline for TB Diagnostics

Wilber Sabiiti

School of Medicine
Infection and Global Health Division

Press/Media: Relating to Research

Description

TB-MBLA has been listed among tuberculosis diagnostics in the development pipeline by Treatment action group. Addition to the list gives visiility and increases potential for attracting investment to commercialise the test. pipeline_TB_diagnostics_2021_final.pdf (treatmentactiongroup.org)

Period	30 Nov 2021

Media contributions

Title	Tuberculosis Molecular Bacterial Load Assay (TB-MBLA) listed in the TB Diagnostics pipeline.
Country/Territory	United Kingdom
Date	30/11/21
Description	The St Andrews developed TB-MBLA was listed by the Treatment Action Group USA. TB-MBLA is the first of its kind to measure the patient TB bacterial load.
Producer/Author	Dr Wilber Sabiiti and Prof Gillespie
URL	https://www.treatmentactiongroup.org/wp-content/uploads/2021/11/pipeline_TB_diagnostics_2021_final.pdf
Persons	Wilber Sabiiti

View all 1

View less